1887

n Cardiovascular Journal of South Africa - INSIGHT shows value of calcium antagonist (nifedipine) in diabetic hypertension : drug trends in cardiology

USD

 

Abstract

Extracted from text ... INSIGHT shows value of calcium antagonist (nifedipine) in diabetic hypertension The INSIGHT study, which demonstrated that nifedipine (Adalat XL) and diuretic therapy with co-amilozide had a comparable efficacy in preventing overall cardiovascular and cerebrovascular complications in patients with hypertension, has recently been evaluated with regard to cardiovascular outcomes in patients with diabetes at baseline (1 302 patients).1 This evaluation found that significantly fewer nifedipine-treated patients with diabetes had secondary outcomes (a composite of all-cause death, death from a vascular cause, and death from a non-vascular cause) than co-amilozidetreated patients (14.2% vs 18.7%: relative risk, 0.76; 95% CI, 0.59, 1.42; P ..

Loading

Article metrics loading...

/content/cardio/14/4/EJC23847
2003-07-01
2016-12-02
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error